DIBOA-Glucoside
DIBOA-Glucoside is a glycoside derivative that can be found in cereal crops like rye, wheat, and maize. DIBOA-Glucoside is a stable, less toxic glucoside form of DIBOA. DIBOA-Glucoside, upon pest or pathogen attack, is hydrolyzed by an enzyme, releasing the toxic aglycone DIBOA and glucose, thereby deterring insects and suppressing weeds through an allelopathic effect.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- CAS. Nr.: 155835-54-4
- Formel: C14H17NO9
- Molecular Weight:343.29
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biologische Aktivität
-
Chemical Information
- Protokoll
- Reinheit & Dokumentation
- Verweise
-
Help & FAQs
Biologische Aktivität
Beschreibung
In Vitro
DIBOA-Glucoside (compound 1a) is present in fresh tissues of Acanthus mollis, A. spinosus, Aphelandra aurantiaca, A. squarrosa, Crossandra infundibuliformis, and Scoparia dulcis, where enzymatic hydrolysis releases DIBOA in Crossandra infundibuliformis tissues[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
Chemical Information
-
CAS. Nr. 155835-54-4
-
Molecular Weight 343.29
-
Formel C14H17NO9
-
SMILES
ON1C2=CC=CC=C2O[C@@H](C1=O)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O
-
Structure Classification
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Protokoll
-
Research Protocol for Infectious Diseases
Infectious-disease experiments test how pathogens interact with host barriers, innate immune receptors, inflammatory signaling, pathogen replication, and tissue injury; pattern-recognition receptors such as TLRs, RIG-I-like receptors, NOD-like receptors, and inflammasomes detect microbial molecules and activate NF-κB, interferon, and cytokine responses. The central hypothesis is that infection severity reflects the balance between pathogen burden and host response: protective inflammation restricts pathogen growth, whereas excessive or mislocalized inflammation contributes to tissue damage and disease phenotype. Unresolved questions include which host pathways are protective versus pathogenic, why some infection models fail to translate to human disease, and which combined readouts best predict clinically relevant infection outcomes.
Reinheit & Dokumentation
Verweise
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)
DIBOA-Glucoside Related Classifications
HY-W750858 Related Classifications
Powered by Bioz